Investment in US refineries is on the upswing due to increased profitability. Driven by higher oil prices, rising demand and years of underinvestment, US refining margins remain healthy. According to Wood Mackenzie, US demand for gas is forecasted to outpace supply over the next three years due, in part, to shutdowns of refineries, as upgrades […]
Upcoming moves by the FDA could spur a number of pharmacogenomic studies for warfarin and eventually bring pharmacogenomic tests into the mainstream. The Food and Drug Administration is considering changes to the label of warfarin, a popular anticoagulant, that warn consumers of the drug’s varying effects on people depending on their genotypes. While there are […]
This month, the EPA published the “Framework for Metals Risk Assessment,” which examines the special attributes and behaviors of metals and metal compounds from the perspective of their effects on human health and the environment, and recommends strategies for future research by EPA risk assessors. As concentrations of environmental metals varies around the country, the […]
Public funding sources in the EU and Australia are establishing programs to assist biotechnology projects that are trying to negotiate the so-called “valley of death”—the funding gap that lies between academic grants and industrial licensing or venture capital backing. The European Investment Fund entered into a €8 million ($10.6 million) partnership with Belgium’s University of […]
The FDA plans to define the term “gluten-free” for the purposes of food labeling. The FDA has produced a draft proposal in January and is accepting comments on the proposal until April. According to the FDA, a gluten-free food does not contain wheat, rye or barley; it also should not contain any ingredient made from […]
According to a survey by Chemical & Engineering News, the 16 chemical firms that gave answers about capital spending will increase capital spending by an average of 7.6% this year. Increases of 28.1% and 16.5% were recorded in 2005 and 2006, respectively. Among the firms, the largest increase in capital investments, 36.4%, will be recorded […]
M&A activity among pharmaceutical outsourcing companies in 2006 was rapid. In this highly fragmented industry, consolidation often marked companies’ interest in establishing an international reach. Covalent Group’s acquisition of Remedium Oy is an example of this. Another trend was a shift among private equity firms towards expanding their portfolio outsourcing companies with an eye on […]
The Environmental Protection Agency (EPA) announced regulations last week that will lower airborne pollutants over the next 25 years. Most significantly for oil refineries, the rules require that benzene levels be cut. On average, benzene made up roughly 1% of US gas in 2004. This proportion will be brought down to an average of 0.62% […]
The editors of R&D Magazine and analysts from Batelle expect that total R&D spending in the US will rise 2.85% to $338.3 billion in 2007. Industry spending is forecast to account for $243.9 billion, a 3.30% increase from 2006, and academia is predicted to do $52.2 billion worth of work on R&D, a 1.83% increase. […]
The global area of biotech crops grew 13% to 102 million hectares (252 million acres) in 2006. The US leads the world, with 54.6 million hectares (134.9 million acres) of biotech crops, followed by Argentina with 18 million hectares (44.5 million acres) and Brazil with 11.5 million hectares (28.4 million acres). India posted the largest […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.